Dihydrofuro pyrimidines as AKT protein kinase inhibitors
US8329701B2 · kind B2 · utility
12Cited by
24References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 2007 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | May 8, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula (I): Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.